15th Community Wide Experiment on the
Critical Assessment of Techniques for Protein Structure Prediction
3D structure evaluation - Targets and Domains count: 37
Results Home Table Browser
Results for Group: 
First Models | All Models All Classifications | TBM | FM All Targets | Server | Human/Server

T1104-D1

(FM) H/S (90.25) Range: 1-117

T1106s1-D1

(FM/TBM) H/S (80.77) Range: 50-120

T1106s2-D1

(TBM-easy) H/S (94.85) Range: 2-112

T1109-D1

(TBM-easy) H/S (91.46) Range: 7-209,216-226

T1110-D1

(TBM-easy) H/S (96.28) Range: 7-227

T1112-D1

(FM/TBM) H/S (78.32) Range: 1-460

T1113-D1

(FM) H/S (91.54) Range: 1-192

T1114s1

() H/S (45.26) Residues: 189

T1114s1-D1

(FM/TBM) H/S (85.35) Range: 20-79

T1114s1-D2

(other) H/S (69.35) Range: 80-189

T1114s2-D1

(TBM-easy) H/S (95.70) Range: 48-369

T1114s3-D1

(TBM-easy) H/S (97.42) Range: 4-516

T1115

() H/S (67.07) Residues: 288

T1115-D1

(TBM-easy) H/S (87.58) Range: 25-200

T1115-D2

(TBM-easy) H/S (63.23) Range: 201-272

T1119-D1

(TBM-hard) H/S (99.40) Range: 7-54

T1120-D1

(FM) H/S (87.97) Range: 8-125

T1120-D2

(FM) H/S (88.93) Range: 126-235

T1121

() H/S (58.85) Residues: 381

T1121-D1

(FM) H/S (86.36) Range: 2-204

T1121-D2

(TBM-hard) H/S (94.72) Range: 205-381

T1122-D1

(FM) H/S (31.05) Range: 4-237

T1123-D1

(FM/TBM) H/S (78.23) Range: 33-258

T1124-D1

(TBM-easy) H/S (88.29) Range: 7-384

T1125

() H/S (17.12) Residues: 1200

T1125-D1

(FM) H/S (38.04) Range: 327-460

T1125-D2

(FM) H/S (55.57) Range: 461-608

T1125-D3

(TBM-hard) H/S (70.52) Range: 609-797

T1125-D4

(FM) H/S (62.48) Range: 798-946

T1125-D5

(FM) H/S (41.91) Range: 947-1096

T1125-D6

(FM) H/S (42.56) Range: 1097-1162

T1127-D1

(TBM-hard) H/S (93.42) Range: 6-210

T1129s2-D1

(FM) H/S (77.59) Range: 33-640

T1130-D1

(FM) H/S (44.10) Range: 28-133,139-195

T1131-D1

(FM) H/S (19.97) Range: 1-161

T1132-D1

(TBM-easy) H/S (99.29) Range: 5-102

T1133-D1

(TBM-easy) H/S (94.18) Range: 4-427

Protein Structure Prediction Center
Sponsored by the US National Institute of General Medical Sciences (NIH/NIGMS)
Please address any questions or queries to:
© 2007-2022, University of California, Davis